4//SEC Filing
Schneider Bruce E. 4
Accession 0001181431-13-001291
CIK 0001389870other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:22 PM ET
Size
7.8 KB
Accession
0001181431-13-001291
Insider Transaction Report
Form 4
Schneider Bruce E.
DirectorChief Executive Officer
Transactions
- Award
Warrants (Right to Buy)
2013-01-01+1,500,000→ 1,500,000 totalExercise: $0.30Exp: 2020-01-01→ Common Stock (1,500,000 underlying) - Award
Warrants (Right to Buy)
2013-01-01+1,500,000→ 1,500,000 totalExp: 2020-01-01→ Common Stock (1,500,000 underlying)
Footnotes (3)
- [F1]Fifty percent (50%) of the warrants vested and became exercisable on January 1, 2013. The remaining warrants vest and become exercisable on June 30, 2013, provided that the reporting person remains employed with the issuer on the vesting date.
- [F2]The exercise price is the equal to the lower of $1.00 per share or the market price of the issuer's common stock on each date that certain milestones are achieved.
- [F3]The warrants vest and become exercisable upon the achievement of certain milestones by the issuer.
Documents
Issuer
OMNI BIO PHARMACEUTICAL, INC.
CIK 0001389870
Entity typeother
Related Parties
1- filerCIK 0001565507
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:22 PM ET
- Size
- 7.8 KB